Viewing nowGlyrep (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Bainex Co., Ltd.

MFDS item code 200607743 · Notified 2006.08.23 · Insurance code 643100670
Treatment of type 2 diabetes mellitus in adults
This medication is used in the treatment of adults with type 2 diabetes who have difficulty controlling blood sugar levels with diet and exercise alone, especially in overweight diabetic patients. It can be used alone or in combination with other oral hypoglycemic agents or insulin to help effectively manage blood sugar levels. It contributes to the prevention of diabetes complications by improving blood sugar control.
The dosage should be determined individually based on efficacy and tolerability and should not exceed the recommended maximum daily dose. - The usual starting dose is 500mg of metformin hydrochloride extended-release tablets once daily with the evening meal. - Blood glucose levels should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase by 500mg each week. The dose may be increased to a maximum of 2000mg per day, taken with the evening meal. If glycemic control is not achieved with a maximum once-daily dose of 2000mg, consider administering 1000mg twice daily; both doses should be taken with meals. - For patients already receiving metformin tablets, the starting dose of this formulation is the same as the daily dose of immediate-release metformin tablets. Switching to this formulation is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - At treatment initiation and during dose adjustment, fasting blood glucose should be measured to assess the therapeutic response and determine the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. - The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with stage 3a moderate renal impairment (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be closely monitored every 3- 6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73m2, respectively, treatment with this medicine should be discontinued immediately.
This medication can rarely cause a serious side effect called lactic acidosis, so it is important to be aware of this condition. Lactic acidosis is a state that occurs when lactic acid builds up excessively in the body and can be very dangerous. Caution is needed when this medication is used in conjunction with other diabetes medications like insulin or sulfonylureas, as severe hypoglycemia can occur. This medication should not be used in patients with moderate to severe renal impairment or in acute conditions such as dehydration, severe infections, heart failure, or acute myocardial infarction. Additionally, it should be temporarily discontinued if iodinated contrast agents are used for radiologic examinations. It is not administered to patients with hypersensitivity to this drug, patients with type 1 diabetes, or patients with a history of lactic acidosis or ketoacidosis. During severe infections, trauma, or surgical procedures, this medication should be temporarily discontinued and restarted once the patient's condition stabilizes. Caution should also be exercised in patients with poor nutritional status, liver function abnormalities, respiratory failure, or excessive alcohol consumption. Kidney function should be monitored regularly while on this medication, and it should be discontinued if renal function declines. Hypoglycemia symptoms may occur, particularly if taken with other hypoglycemic agents or when food intake is insufficient. Gastrointestinal disturbances such as nausea, vomiting, and diarrhea may occur during use, but these symptoms typically improve with time and gradual dosage increases. This medication can cross the placenta during pregnancy, so it should be used with caution and under a healthcare provider's supervision during this time. It is not recommended during breastfeeding. Elderly patients may have an increased risk of kidney function decline, so dosage adjustment and regular renal function monitoring are necessary. There may be interactions with other medications; thus, patients must inform their physician or pharmacist about any other medications they are taking. This medication should be swallowed whole and not chewed or crushed; the tablet coating may pass through in the stool, which is a normal occurrence. Patients should avoid excessive alcohol consumption while taking this medication, and their blood sugar and renal function should be monitored regularly.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, ideally at a cool temperature below 25 degrees Celsius. This will help maintain the effectiveness of the medication for a longer period.
White to light yellow oblong tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Bainex Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.